Sai Ravi Pingali, MD

Assistant Professor of Clinical Medicine in Oncology, Institute for Academic Medicine
Houston Methodist
Weill Cornell Medical College


Biography

Dr. Pingali is board certified by the American Board of Internal Medicine in medical oncology and hematology. His primary focus is on hematologic malignancies and stem cell transplantation. After completing his medical training in India, Dr. Pingali received training in various reputable programs in the United Kingdom as part of senior house officer training after which he moved to the United States. He completed his residency in internal medicine at Gundersen Lutheran Medical Center in Wisconsin. He then completed a fellowship in hematology and oncology at the Medical College of Wisconsin, and a fellowship in stem cell transplantation at the University of Texas MD Anderson Cancer Center.

Dr. Pingali is a member of the American Society of Clinical Oncology, American Society of Hematology and the American Society for Blood and Marrow Transplantation. He sees patients at Houston Methodist Hospital.

Active Clinical Trials

A PHASE Ib STUDY OF THE SAFETY AND

NCT02431208

Publications

Acute myeloid leukemia with eosinophilia after cyclin-dependent kinases 4/6 inhibitor treatment due to underlying clonal hematopoiesis of indeterminate potential
Anand, K, Kumar, P, Pingali, SR, Pati, D & Iyer, SP 2019, American Journal of Hematology. https://doi.org/10.1002/ajh.25380

Use of PEG-asparaginase in a case of Hepatosplenic ?d T-cell lymphoma with long-term remission after stem cell transplantation
Sun, K, Sanchez, CG, Pingali, SR & Iyer, S 2018, ecancermedicalscience, vol. 12, 872. https://doi.org/10.3332/ecancer.2018.872

Complete Local and Abscopal Responses from a Combination of Radiation and Nivolumab in Refractory Hodgkin's Lymphoma
Qin, Q, Nan, X, Miller, TN, Fisher, R, Teh, BS, Pandita, S, Farach, AM, Pingali, SR, Pandita, RK, Butler, EB, Pandita, TK & Iyer, SP 2018, Radiation Research, vol. 190, no. 3, pp. 322-329. https://doi.org/10.1667/RR15048.1

Immune Checkpoint Inhibitor-Related Cardiotoxicity
Trachtenberg, BH, Hussain, F, Mukherjee, A, Araujo-Gutierrez, R & Pingali, SR 2018, Methodist DeBakey cardiovascular journal, vol. 14, no. 3. https://doi.org/10.14797/mdcj-14-3-e1

Cryptococcal meningoencephalitis in patients with mantle cell lymphoma on ibrutinib
Sun, K, Kasparian, S, Iyer, S & Pingali, SR 2018, ecancermedicalscience, vol. 12, 836. https://doi.org/10.3332/ecancer.2018.836

Bacterial blood stream infections (BSIs), particularly post-engraftment BSIs, are associated with increased mortality after allogeneic hematopoietic cell transplantation
Ustun, C, Young, JAH, Papanicolaou, GA, Kim, S, Ahn, KW, Chen, M, Abdel-Azim, H, Aljurf, M, Beitinjaneh, A, Brown, V, Cerny, J, Chhabra, S, Kharfan-Dabaja, MA, Dahi, PB, Daly, A, Dandoy, CE, Dvorak, CC, Freytes, CO, Hashmi, S, Lazarus, H, Ljungman, P, Nishihori, T, Page, K, Pingali, SR, Saad, A, Savani, BN, Weisdorf, D, Williams, K, Wirk, B, Auletta, JJ, Lindemans, CA, Komanduri, K & Riches, M 2018, Bone Marrow Transplantation. https://doi.org/10.1038/s41409-018-0401-4

Use of PEG-asparaginase in monomorphic epitheliotropic intestinal T-cell lymphoma, a disease with diagnostic and therapeutic challenges
Gentille, C, Qin, Q, Barbieri, A, Pingali, SR & Iyer, S 2017, ecancermedicalscience, vol. 11, 771. https://doi.org/10.3332/ecancer.2017.771

Anemia after continuous-flow left ventricular assist device implantation: Characteristics and implications
Amione-Guerra, J, Cruz-Solbes, AS, Bhimaraj, A, Trachtenberg, BH, Pingali, SR, Estep, JD, Park, MH & Guha, A 2017, International Journal of Artificial Organs, vol. 40, no. 9, pp. 481-488. https://doi.org/10.5301/ijao.5000607

Effect of Routine Surveillance Imaging on the Outcomes of Patients With Classical Hodgkin Lymphoma After Autologous Hematopoietic Cell Transplantation
Kapke, JT, Epperla, N, Shah, N, Richardson, K, Carrum, G, Hari, PN, Pingali, SR, Hamadani, M, Karmali, R & Fenske, TS 2017, Clinical Lymphoma, Myeloma and Leukemia, vol. 17, no. 7, pp. 408-414. https://doi.org/10.1016/j.clml.2017.05.005

Age over Fifty-Five Years at Diagnosis Increases Risk of Second Malignancies after Autologous Transplantation for Patients with Hodgkin Lymphoma
Pingali, SR, Saliba, RM, Anderlini, P, Hosing, C, Khouri, I, Alousi, AM, Nieto, Y, Qazilbash, MH, Champlin, R & Popat, UR 2017, Biology of Blood and Marrow Transplantation, vol. 23, no. 7, pp. 1059-1063. https://doi.org/10.1016/j.bbmt.2017.03.030

High-dose gemcitabine, busulfan, and melphalan for autologous stem-cell transplant in patients with relapsed or refractory myeloma: a phase 2 trial and matched-pair comparison with melphalan
Nieto, Y, Valdez, BC, Pingali, SR, Bassett, R, Delgado, R, Nguyen, J, Shah, N, Popat, U, Jones, RB, Andersson, BS, Gulbis, A, Ahmed, S, Bashir, Q, Parmar, S, Patel, K, Myers, A, Rondon, G, Orlowski, RZ, Champlin, R & Qazilbash, M 2017, The Lancet Haematology, vol. 4, no. 6, pp. e283-e292. https://doi.org/10.1016/S2352-3026(17)30080-7

Patient age and number of apheresis days may predict development of secondary myelodysplastic syndrome and acute myelogenous leukemia after high-dose chemotherapy and autologous stem cell transplantation for lymphoma
Ge, I, Saliba, RM, Maadani, F, Popat, UR, Qazilbash, MH, Ravi Pingali, S, Shah, N, Ahmed, S, Bashir, Q, Nieto, Y, Champlin, RE & Hosing, C 2017, Transfusion. https://doi.org/10.1111/trf.14016

Leukapheresis reduces 4-week mortality in acute myeloid leukemia patients with hyperleukocytosis – a retrospective study from a tertiary center
Nan, X, Qin, Q, Gentille, C, Ensor, J, Leveque, C, Pingali, R, Phan, AT, Rice, L & Iyer, S 2017, Leukemia and Lymphoma, pp. 1-11. https://doi.org/10.1080/10428194.2016.1277386

Prevention of Cytomegalovirus Reactivation in Haploidentical Stem Cell Transplantation
Hammerstrom, AE, Lombardi, LR, Pingali, SR, Rondon, G, Chen, J, Milton, DR, Chemaly, RF, Champlin, RE, Gulbis, A & Ciurea, SO 2017, Biology of Blood and Marrow Transplantation. https://doi.org/10.1016/j.bbmt.2017.09.018

Impact of Routine Surveillance Imaging on Outcomes of Patients With Diffuse Large B-Cell Lymphoma After Autologous Hematopoietic Cell Transplantation
Epperla, N, Shah, N, Hamadani, M, Richardson, K, Kapke, JT, Patel, A, Teegavarapu, SP, Carrum, G, Hari, PN, Pingali, SR, Karmali, R & Fenske, TS 2016, Clinical Lymphoma, Myeloma and Leukemia, vol. 16, no. 12, pp. 672-678. https://doi.org/10.1016/j.clml.2016.08.018

Pushing the envelope-nonmyeloablative and reduced intensity preparative regimens for allogeneic hematopoietic transplantation
Pingali, SR & Champlin, RE 2015, Bone Marrow Transplantation, vol. 50, no. 9, pp. 1157-67. https://doi.org/10.1038/bmt.2015.61

Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia
Ciurea, SO, Zhang, M-J, Bacigalupo, AA, Bashey, A, Appelbaum, FR, Aljitawi, OS, Armand, P, Antin, JH, Chen, J, Devine, SM, Fowler, DH, Luznik, L, Nakamura, R, ODonnell, PV, Perales, M-A, Pingali, SR, Porter, DL, Riches, MR, Ringdén, OTH, Rocha, V, Vij, R, Weisdorf, DJ, Champlin, RE, Horowitz, MM, Fuchs, EJ & Eapen, M 2015, Blood, vol. 126, no. 8, pp. 1033-40. https://doi.org/10.1182/blood-2015-04-639831

Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donors
Di Stasi, A, Milton, DR, Poon, LM, Hamdi, A, Rondon, G, Chen, J, Pingali, SR, Konopleva, M, Kongtim, P, Alousi, A, Qazilbash, MH, Ahmed, S, Bashir, Q, Al-atrash, G, Oran, B, Hosing, CM, Kebriaei, P, Popat, U, Shpall, EJ, Lee, DA, de Lima, M, Rezvani, K, Khouri, IF, Champlin, RE & Ciurea, SO 2014, Biology of Blood and Marrow Transplantation, vol. 20, no. 12, pp. 1975-81. https://doi.org/10.1016/j.bbmt.2014.08.013

Leptomeningeal carcinomatosis associated with papillary renal cell carcinoma
Chilkulwar, A, Pottimutyapu, R, Wu, F, Padooru, KR, Pingali, SR & Kassem, M 2014, ecancermedicalscience, vol. 8, pp. 468. https://doi.org/10.3332/ecancer.2014.468

Limited utility of routine surveillance imaging for classical Hodgkin lymphoma patients in first complete remission
Pingali, SR, Jewell, SW, Havlat, L, Bast, MA, Thompson, JR, Eastwood, DC, Bartlett, NL, Armitage, JO, Wagner-Johnston, ND, Vose, JM & Fenske, TS 2014, Cancer, vol. 120, no. 14, pp. 2122-9. https://doi.org/10.1002/cncr.28698